Wednesday, December 9th 10:30 am-11:30 am PST| 1:30 pm-2:30 pm EST
Mario S. Izidoro Jr., Ph.D., Technical Support Scientist, Novogene Corporation Inc.
Mario Izidoro has a pharmacy degree and a master’s degree in biochemistry and human physiology. During his PhD at UC Davis, Mario developed and characterized an in vitro approach to measure parameters of enzyme kinetics of translation initiation factors in steady states and pre steady states using fluorescence. He is currently working as a technical support scientist at Novogene.
RNA is a single-stranded nucleic acid polymer of the four nucleotides A, C, G, and U joined through a backbone of alternating phosphate and ribose residues, converting the information from DNA into proteins or some serve direct roles in cell, like rRNA, tRNA. Among all kinds of RNAs in cells, messenger RNA (mRNA) is a molecular that carries codes from the DNA in the nucleus to the sites of protein synthesis in the cytoplasm (the ribosomes), and nowadays, the prevailed next generation sequencing has been widely used to sequence mRNA (mRNA-Seq), to profile the snapshot of mRNA or even the entire transcriptome at a given moment in time.
Novogene’s mRNA-Seq, based on state-of-the-art Illumina NovaSeq platforms with paired-end 150 bp sequencing strategy, offers comprehensive solutions for analysis of gene expression quantification and differential gene expression among sample groups, as well as for identification of novel transcripts, alternative splicing, gene fusion events, and etc.
Besides the standard analysis for species with or without a reference genome mentioned above, our experienced bioinformaticians also dedicate advanced analysis to client, such as PDX (Patient-Derived Xenograft) mold analysis to find out how patient’s tumor develops after treatment, dual RNA-Seq analysis for understanding host-pathogen interactions, and more. What’s more, customized data analysis services for your unique special requirements are also available whenever you need.
The webinar will consist of a 30 minutes’ presentation followed by a live Q&A session.